Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02288910 · ClinicalTrials.gov registry record
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT02288910 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT02288910 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This project investigates the feasibility of assessing the relative blood volume of carcinomas in patients with Hepatocellular Carcinoma (HCC) and liver metastases from pancreatic or colorectal cancer compared to normal liver from DynaCT acquisitions on an interventional platform.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-11 |
| Est. Completion | 2020-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02288910
The ClinicalTrials.gov registry entry for NCT02288910 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02288910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02288910 about?
NCT02288910 is a clinical study titled "Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver". This project investigates the feasibility of assessing the relative blood volume of carcinomas in patients with Hepatocellular Carcinoma (HCC) and liver metastases from pancreatic or colorectal cancer compared to normal liver from DynaCT acquisitions on an interventional platform.
What is the current status of trial NCT02288910?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2014-11. Estimated completion is 2020-07.
Who is sponsoring clinical trial NCT02288910?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.